ID | 68364 |
FullText URL | |
Author |
Sato, Ryosuke
Department of Gastroenterology and Hepatology, Okayama University Hospital
Matsumoto, Kazuyuki
Department of Gastroenterology and Hepatology, Okayama University Hospital
ORCID
Kaken ID
publons
Uka, Mayu
Department of Radiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Takagi, Kosei
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Nishida, Kenji
Department of Pathology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Tanaka, Takehiro
Department of Pathology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
ORCID
Kaken ID
publons
Fujii, Yuki
Department of Gastroenterology and Hepatology, Okayama University Hospital
Tsutsumi, Koichiro
Department of Gastroenterology and Hepatology, Okayama University Hospital
ORCID
Kaken ID
researchmap
Horiguchi, Shigeru
Department of Gastroenterology and Hepatology, Okayama University Hospital
Otsuka, Motoyuki
Department of Gastroenterology and Hepatology, Okayama University Hospital
|
Abstract | We herein report a case of pancreatic ductal adenocarcinoma (PDAC) that developed within the pancreatic duct and was initially diagnosed as an intraductal tubulopapillary neoplasm (ITPN). A 76-year-old man presented with weight loss and main pancreatic duct dilation. The imaging studies revealed a 30-mm hypovascular tumor within the main duct of the pancreatic head. An endoscopic examination with a biopsy revealed high-grade atypical epithelial cells with immunostaining patterns suggestive of ITPN. Following robot-assisted pancreaticoduodenectomy, postoperative pathology revealed conflicting features: nodular/cribriform infiltrations typical of ITPN and non-lobular replacement with scattered infiltrations characteristic of PDAC. A comprehensive genomic profiling test detected KRAS and TP53 mutations, leading to the final diagnosis of PDAC (fT3N1aM0, stage IIB). The patient received adjuvant S-1 chemotherapy and remained recurrence-free for 15 months post-surgery. This case highlights the diagnostic challenges of differentiating intraductal pancreatic tumors and demonstrates the utility of integrating genetic testing with conventional diagnostic modalities for an accurate diagnosis and appropriate treatment selection.
|
Keywords | Pancreatic intraductal neoplasms
Pancreatic carcinoma
Intraductal tubulopapillary neoplasm
Genetic testing
|
Note | The version of record of this article, first published in Clinical Journal of Gastroenterology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s12328-025-02098-y
|
Published Date | 2025-02-05
|
Publication Title |
Clinical Journal of Gastroenterology
|
Volume | volume18
|
Issue | issue2
|
Publisher | Springer Science and Business Media LLC
|
Start Page | 376
|
End Page | 382
|
ISSN | 1865-7257
|
Content Type |
Journal Article
|
language |
English
|
OAI-PMH Set |
岡山大学
|
Copyright Holders | © The Author(s) 2025
|
File Version | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
Related Url | isVersionOf https://doi.org/10.1007/s12328-025-02098-y
|
License | http://creativecommons.org/licenses/by/4.0/
|
Citation | Sato, R., Matsumoto, K., Uka, M. et al. A case of pancreatic ductal adenocarcinoma growing within the pancreatic duct mimicking an intraductal tubulopapillary neoplasm. Clin J Gastroenterol 18, 376–382 (2025). https://doi.org/10.1007/s12328-025-02098-y
|
Funder Name |
Okayama University
|